TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received a notice (the “Notice”) on March 19, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the company that it was not in compliance with Nasdaq’s…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
